NOELLE FALKENBERRY: Open Payments
NPI 1861986788 · MONROEVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 65 payments from 28 companies in 2025. Trend: 2023 $1,194 · 2024 $1,163 · 2025 $1,297
Food & beverage: $1,198Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $179 |
| Janssen Biotech, Inc. | 4 | $150 |
| Merck Sharp & Dohme LLC | 6 | $121 |
| Incyte Corporation | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 5 | $90 |
| Stemline Therapeutics Inc. | 3 | $72 |
| Lilly USA, LLC | 3 | $53 |
| Pharmacosmos Therapeutics Inc. | 2 | $50 |
| Eisai Inc. | 3 | $49 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
Products named: DARZALEX, KISQALI, KEYTRUDA, JAKAFI, LIBTAYO, Orserdu, VERZENIO, MONOFERRIC.
Industry payments across AL — which companies pay providers there.
